Abstract
Background and purpose Rituximab, a chimeric anti-CD20 monoclonal antibody, has been used in polyneuropathy associated with anti-myelin-associated gly......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
